Evidence map›Paper›PMID 27058906›Full record

Trial reportJournal of the American College of Cardiology2016

Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study.

Klaus K Witte, Rowena Byrom, John Gierula, Maria F Paton, Haqeel A Jamil, Judith E Lowry, Richard G Gillott, Sally A Barnes, Hemant Chumun, Lorraine C Kearney and 7 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American College of Cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01619891 (VitamIN D Treating patIents With Chronic heArT failurE), which is not on this map. Cited by 106 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 9 pooled it
24.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01619891 phase2completednot on this map

VitamIN D Treating patIents With Chronic heArT failurE

TypeinterventionalSponsorUniversity of LeedsRan2012 to 2016Enrolled253ConditionsChronic Heart FailureArmsVitamin D
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 9 syntheses or guidelines pooled it, 223 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Efficacy of vitamin DAgeing research reviews · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Vitamin DBMC cardiovascular disorders · 2017
    Trial
  15. Trial
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Klaus K WitteLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom. Electronic address: k.k.witte@leeds.ac.uk.
Rowena ByromLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
John GierulaLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Maria F PatonLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Haqeel A JamilLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Judith E LowryLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Richard G GillottLeeds Teaching Hospitals NHS Trust, Department of Cardiology, Leeds, United Kingdom.
Sally A BarnesLeeds Teaching Hospitals NHS Trust, Department of Cardiology, Leeds, United Kingdom.
Hemant ChumunLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Lorraine C KearneyLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
John P GreenwoodLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Sven PleinLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Graham R LawLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Sue PavittSchool of Dentistry, University of Leeds, Leeds, United Kingdom.
Julian H BarthLeeds Teaching Hospitals NHS Trust, Department of Clinical Biochemistry, Leeds, United Kingdom.
Richard M CubbonLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Mark T KearneyLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
University of Leeds · GBLeeds Teaching Hospitals NHS Trust · GB

Funding

British Heart Foundation FS/10/028/28252British Heart Foundation FS/12/80/29821British Heart Foundation RG/09/010/28087Department of Health HCS DRF-2014-05-006Medical Research Council MR/J00281X/1
6 · The paper itself

Abstract

backgroundPatients with chronic heart failure (HF) secondary to left ventricular systolic dysfunction (LVSD) are frequently deficient in vitamin D. Low vitamin D levels are associated with a worse prognosis.

objectivesThe VINDICATE (VitamIN D treatIng patients with Chronic heArT failurE) study was undertaken to establish safety and efficacy of high-dose 25 (OH) vitamin D3 (cholecalciferol) supplementation in patients with chronic HF due to LVSD.

methodsWe enrolled 229 patients (179 men) with chronic HF due to LVSD and vitamin D deficiency (cholecalciferol <50 nmol/l [<20 ng/ml]). Participants were allocated to 1 year of vitamin D3 supplementation (4,000 IU [100 μg] daily) or matching non-calcium-based placebo. The primary endpoint was change in 6-minute walk distance between baseline and 12 months. Secondary endpoints included change in LV ejection fraction at 1 year, and safety measures of renal function and serum calcium concentration assessed every 3 months.

resultsOne year of high-dose vitamin D3 supplementation did not improve 6-min walk distance at 1 year, but was associated with a significant improvement in cardiac function (LV ejection fraction +6.07% [95% confidence interval (CI): 3.20 to 8.95; p < 0.0001]); and a reversal of LV remodeling (LV end diastolic diameter -2.49 mm [95% CI: -4.09 to -0.90; p = 0.002] and LV end systolic diameter -2.09 mm [95% CI: -4.11 to -0.06 p = 0.043]).

conclusionsOne year of 100 μg daily vitamin D3 supplementation does not improve 6-min walk distance but has beneficial effects on LV structure and function in patients on contemporary optimal medical therapy. Further studies are necessary to determine whether these translate to improvements in outcomes. (VitamIN D Treating patIents With Chronic heArT failurE [VINDICATE]; NCT01619891).

Indexed as

AgedCalcifediolCalcitriolCholecalciferolDouble-Blind MethodEchocardiographyFemaleHeart FailureHeart VentriclesHumansMagnetic Resonance Imaging, CineMaleMiddle AgedStroke VolumeSystoleVentricular Dysfunction, LeftCalcifediolCalcitriolCholecalciferolVitaminsheart failureleft ventricular functionremodelingvitamin D

Identifiers

PMID27058906
PMCPMC4893154
OpenAlexW2338797564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.